We review studies estimating life expectancy (LE), the average number of additional years a
person can expect to live, for HIV-positive adults and show variation by sociodemographic …

Abacavir is a carbocyclic 2′-deoxyguanosine nucleoside analogue. It is metabolised
intracellularly to a 2′-deoxyguanosine nucleoside analogue which competitively inhibits …

Objectives To estimate life expectancy for people with HIV undergoing treatment compared
with life expectancy in the general population and to assess the impact on life expectancy of …

Background The structure of sexual contact networks plays a key role in the epidemiology of
sexually transmitted infections, and their reconstruction from interview data has provided …

Background: The safety of delaying highly active antiretroviral therapy (HAART) in HIV-
infected patients is uncertain when the CD4+ cell count declines below 0.350× 109 cells/L …

Background The optimal sequencing of antiretroviral regimens for the treatment of infection
with human immunodeficiency virus type 1 (HIV-1) is unknown. We compared several …

Background. Many studies of sexual behavior have shown that individuals vary greatly in
their number of sexual partners over time, but it has proved difficult to obtain parameter …

Resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) increases with the
wider use of this class of antiretroviral therapy. The association between adherence and …

Objective: To test the utility of the necessity-concerns framework in predicting highly active
antiretroviral therapy (HAART) uptake and adherence. Methods: This was a prospective …

ContextAbacavir, a nucleoside analogue, has demonstrated suppression of human
immunodeficiency virus (HIV) replication alone and in combination therapy. However, the …